These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19536186)

  • 1. Biotech bailout? A rescue of some sort will be needed to save a large subset of the US biotechnology industry.
    Nat Immunol; 2009 Jul; 10(7):667. PubMed ID: 19536186
    [No Abstract]   [Full Text] [Related]  

  • 2. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotech industry considers foreign competition measure.
    Margolis RE
    Healthspan; 1990 Nov; 7(10):19-20. PubMed ID: 10107734
    [No Abstract]   [Full Text] [Related]  

  • 4. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 5. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 6. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beware the biotech barker.
    Jacobs T
    Nat Biotechnol; 2005 May; 23(5):538. PubMed ID: 15877065
    [No Abstract]   [Full Text] [Related]  

  • 8. The rise of venture capital and biotechnology in the US and Europe.
    Lee DP; Dibner MD
    Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233
    [No Abstract]   [Full Text] [Related]  

  • 9. Will investors return to biotechnology?
    Dorey E
    Nat Biotechnol; 1999 Feb; 17(2):128. PubMed ID: 10052340
    [No Abstract]   [Full Text] [Related]  

  • 10. Do corporate gifts compromise biotech researchers?
    Hoyle R
    Nat Biotechnol; 1998 Jun; 16(6):495. PubMed ID: 9624666
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech sector ponders potential 'bloodbath'.
    Mitchell P
    Nat Biotechnol; 2009 Jan; 27(1):3-4. PubMed ID: 19131974
    [No Abstract]   [Full Text] [Related]  

  • 12. Public biotech 2010--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2011 Jul; 29(7):585-91. PubMed ID: 21747381
    [No Abstract]   [Full Text] [Related]  

  • 13. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology. Bubble, bubble, toil and trouble.
    Boorstin J
    Fortune; 2001 Jun; 143(12):48. PubMed ID: 11409107
    [No Abstract]   [Full Text] [Related]  

  • 15. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Biotech in Russia--Phoenix reborn from the ashes.
    Rabinovich M
    Biotechnol J; 2007 Jul; 2(7):771. PubMed ID: 17615595
    [No Abstract]   [Full Text] [Related]  

  • 17. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 18. What will replace the tech economy?
    Davis S; Meyer C
    Time; 2000 May; 155(21):76-7. PubMed ID: 11765521
    [No Abstract]   [Full Text] [Related]  

  • 19. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechnology soared and fell in a roller-coaster 12 months.
    Gershon D
    Nature; 1992 Nov; 360(6401):200. PubMed ID: 1436101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.